Joseph Beaulieu, Corporate Controller at Epizyme, Inc. (EPZM), sold 1,514 shares at $12.77 ($19K) on 2019-09-03, disclosed to the SEC on 2020-09-03.
Scheduled sale ($19k) by Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.77 | 971 | $12K | 63.9% |
| 2 | $12.88 | 543 | $7K | 36.1% |
| Total | $12.81 avg | 1,514 | $19K | 100% |
| Filing → |
| EPZM | SELL | 2021-02-05 | $3K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $5K | — | Filing → |
| EPZM | SELL | 2020-03-26 | $3K | — | Filing → |